Advertisement
Canada markets closed

  • S&P/TSX

    22,059.03
    -184.99 (-0.83%)
     

  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     

  • DOW

    39,375.87
    +67.87 (+0.17%)
     

  • CAD/USD

    0.7332
    -0.0015 (-0.20%)
     

  • CRUDE OIL

    83.44
    -0.44 (-0.52%)
     

  • Bitcoin CAD

    78,754.79
    +1,541.54 (+2.00%)
     

  • CMC Crypto 200

    1,194.31
    -14.38 (-1.19%)
     

  • GOLD FUTURES

    2,399.80
    +30.40 (+1.28%)
     

  • RUSSELL 2000

    2,026.73
    -9.90 (-0.49%)
     

  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     

  • NASDAQ

    18,352.76
    +164.46 (+0.90%)
     

  • VOLATILITY

    12.48
    +0.22 (+1.79%)
     

  • FTSE

    8,203.93
    -37.33 (-0.45%)
     

  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     

  • CAD/EUR

    0.6762
    -0.0030 (-0.44%)
     

Brazil's Biolab buys Canada's Exzell Pharma

Reuters

SAO PAULO (Reuters) - Brazilian pharmaceutical company Biolab has bought Canadian healthcare business Exzell Pharma, the company said in a statement on Monday.

Biolab's Canadian subsidiary acquired the company, which has sales and marketing infrastructure as well as brands including Swiss Naturals, Salinex, Esoph, and Myoflex.

The deal value was not disclosed. Biolab CEO Cleiton Castro Marques said in the statement the acquisition streghtens the Brazilian company's international activities. Exzell maintains a portfolio focused primarily on gastroenterology, dermatology, vitamins, and supplements.

(Reporting by Tatiana Bautzer; editing by Barbara Lewis)